Current guidelines for the treatment of type 2 diabetes |
Current guidelines for the treatment of type 2 diabetes
Type 2 diabetes is associated with high risk of cardiovascular disease, eye disease, kidney disease, nerve damage and nerve pain. Effective treatment is of paramount importance, ... |
Education for people with diabetes |
Education for people with diabetes
The prevalence of diabetes in the UK is currently around 6%, which means that approximately 3.2 million UK adults suffer from diabetes. Of these, approximately 90% have type 2 diabetes and it is thought that ... |
Type 1 diabetes: clinical review |
Content developed by MIMS Learning https://www.mimslearning.co.uk/
INTRODUCTION
Type 1 diabetes (T1DM) affects around 1 in 300 people in the UK, but its ... |
Type 2 Diabetes: Diagnosis |
Content developed by Clarity Informatics, providers of online solutions to support the nursing community through appraisals and ... |
Type 2 Diabetes: Management |
Content developed by Clarity Informatics, providers of online solutions to support the nursing community through appraisals and ... |
Targets for glycaemic control in type 2 diabetes |
This promotional module has been initiated, funded and reviewed by Boehringer Ingelheim. The content of this industry-supported learning activity has been generated ... |
Renal considerations in patients with type 2 diabetes |
This promotional module has been initiated, funded and reviewed by Boehringer Ingelheim. The content of this industry-supported learning activity has been generated by ... |
Tailoring therapy to the individual patient |
This promotional module has been initiated, funded and reviewed by Boehringer Ingelheim. The content of this industry-supported learning activity has been generated by ... |
Short-term complications of type 2 diabetes |
This promotional module has been initiated, funded and reviewed by Boehringer Ingelheim. The content of this industry-supported learning activity has been generated by ... |
Cardiovascular considerations in patients with type 2 diabetes |
This promotional module has been initiated, funded and reviewed by Boehringer Ingelheim. The content of this industry-supported learning activity has been generated by ... |
|
|